Securing the NUB and what looks like approval for the Govt backed " Evidence with Benefits" trial where the trial is funded to establish clinical utility/ benefit at a specified price point, is a positive outcome. What needs to be understood is the detail; understanding the trial design; endpoints; what the comparator arm chemo therapy is (is that std of care in Germany or globally); patient numbers status etc. If the trial is powered appropraitely then a positive outcome will be one meaningful step towards success. If the trial were to be negative what would that mean for Oncosil in LAPC ? . The devil is in the detail, smart trial design, patient selection and statistical analysis. One way or the other the question will be answered.
- Forums
- ASX - By Stock
- Ann: Fully-Funded Trial Approved In Germany
Securing the NUB and what looks like approval for the Govt...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
1.1¢ |
Change
0.002(22.2%) |
Mkt cap ! $37.38M |
Open | High | Low | Value | Volume |
1.0¢ | 1.2¢ | 1.0¢ | $271.4K | 26.46M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 7073500 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 75694 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 7073500 | 0.010 |
13 | 8685434 | 0.009 |
17 | 19819493 | 0.008 |
17 | 6571319 | 0.007 |
15 | 20616666 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 75694 | 1 |
0.012 | 6238662 | 9 |
0.013 | 8081519 | 4 |
0.014 | 6863533 | 4 |
0.015 | 200000 | 1 |
Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |